Hematologic Malignancies Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hematologic Malignancies stocks.

Hematologic Malignancies Stocks Recent News

Date Stock Title
Nov 21 INCY Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More
Nov 20 FATE Fate Therapeutics: FT819 Finding Bodes Well For Future Of SLE Treatment Options
Nov 20 CRBU Caribou Biosciences to Participate in Upcoming Investor Conferences
Nov 20 PRTC PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
Nov 19 INCY Equities Close Mostly Higher as Nvidia Jumps Ahead of Earnings; Wall Street Tracking Russia-Ukraine Conflict
Nov 19 INCY Equity Markets Close Mixed Ahead of Nvidia Earnings
Nov 19 INCY S&P 500 Gains and Losses Today: Supermicro Roars Back After Compliance Filing
Nov 19 INCY Sector Update: Health Care Stocks Decline
Nov 19 INCY Top Midday Decliners
Nov 19 INCY Equities Mixed Intraday Amid Growing Russia-Ukraine Conflict
Nov 19 INCY Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
Nov 19 INCY Incyte seesaws on report of potential Merck takeover interest
Nov 19 INCY Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
Nov 19 INCY Incyte Is the S&P 500’s Worst Performer Today. What’s Hitting the Stock.
Nov 19 INCY Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
Nov 19 INCY Incyte Faces Challenges but Remains Focused on Strategic Growth
Nov 19 INCY Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.
Nov 19 FATE Wall Street Breakfast Podcast: Fate Therapeutics Rises On Lupus Drug Data
Nov 19 INCY Incyte sinks on setback for drugs acquired in $750M buyout
Hematologic Malignancies

Hematologic malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematologic malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for hematologic malignancies may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy.

Browse All Tags